Diagnosing cancer, pregnancy complications

August 16, 2012
Diagnosing cancer or pregnancy complications
© Thinkstock

Based on their previous discovery of progesterone-induced blocking factor (PIBF), European scientists have developed a diagnostic assay that could be used to detect pregnancy complications or cancer.

PIBF is a required for maintaining a normal pregnancy. PIBF levels in the urine and blood of healthy pregnant women increase during pregnancy and decrease rapidly during delivery.

Previous work had shown that PIBF levels in women with were significantly lower, and demonstrated that PIBF blocks the autoimmune response which normally leads to the killing of rapidly growing fetal tissue.

Surprisingly, high levels of PIBF have been detected in , suggesting that it constitutes an essential marker for their discovery. The EU-funded PIBF proposal planned to develop a novel testing assay to diagnose malignant tumours, monitor tumour therapy and diagnose premature abortion risk.

Project scientists developed and validated an enzyme-linked immuno sorbent assay (ELISA) for measuring PIBF protein in biological fluids. Although the assay presented with limited sensitivity and precision due to the of the tested protein, it exhibited great reproducibility, making it ideal for inter-laboratory testing.

GMP grade reagents were also produced for the application of the assay in a clinical setting. Studies on clinical samples confirmed the potential role of PIBF in certain pathological pregnancies, and the elevated expression of PIBF in certain cancer patients.

However, similarly to other marketed tumour marker tests, the PIBF ELISA alone did not provide sufficient specificity and sensitivity to be used as a single screening . The developers of this kit are nonetheless hopeful that in combination with other diagnostic tests, this assay will contribute to the higher diagnostic standards of pathological pregnancies and malignant tumours.

Explore further: New prostate cancer test more specific, sensitive than PSA test

Related Stories

New prostate cancer test more specific, sensitive than PSA test

May 16, 2011
A new test for prostate cancer that measures levels of prostate specific antigen (PSA) as well as six specific antibodies found in the blood of men with the disease was more sensitive and more specific than the conventional ...

Study shows that new DNA test to identify Down syndrome in pregnancy is ready for clinical use

October 17, 2011
A new DNA-based prenatal blood test that can strikingly reduce the number of risky diagnostic procedures needed to identify a pregnancy with Down syndrome is ready to be introduced into clinical practice. The test can be ...

Current trend is to preserve pregnancy in patients diagnosed with cervical or ovarian cancer

February 9, 2012
The first paper in The Lancet Series on cancer in pregnancy explores the issues around gynaecological cancers, with cervical and ovarian being the most common. The current trend is to preserve pregnancy wherever possible. ...

Recommended for you

Make way for hemoglobin

August 18, 2017
Every cell in the body, whether skin or muscle or brain, starts out as a generic cell that acquires its unique characteristics after undergoing a process of specialization. Nowhere is this process more dramatic than it is ...

Two-step process leads to cell immortalization and cancer

August 17, 2017
A mutation that helps make cells immortal is critical to the development of a tumor, but new research at the University of California, Berkeley suggests that becoming immortal is a more complicated process than originally ...

Female mouse embryos actively remove male reproductive systems

August 17, 2017
A protein called COUP-TFII determines whether a mouse embryo develops a male reproductive tract, according to researchers at the National Institutes of Health and their colleagues at Baylor College of Medicine, Houston. The ...

New Pathology Atlas maps genes in cancer to accelerate progress in personalized medicine

August 17, 2017
A new Pathology Atlas is launched today with an analysis of all human genes in all major cancers showing the consequence of their corresponding protein levels for overall patient survival. The difference in expression patterns ...

New technique overcomes genetic cause of infertility

August 17, 2017
Scientists have created healthy offspring from genetically infertile male mice, offering a potential new approach to tackling a common genetic cause of human infertility.

Inhibiting a protein found to reduce progression of Alzheimer's and ALS in mice

August 17, 2017
(Medical Xpress)—A team of researchers with Genetech Inc. and universities in Hamburg and San Francisco has found that inhibiting the creation of a protein leads to a reduction in the progression of Alzheimer's disease ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.